Olha Puhach

Dec 5, 2024 | biorxiv.org | Olha Puhach |Eleonore Ostermann |Kyle Rosenke |Laura Staliunaite

AbstractHerpesvirus-based vectors are attractive for use as conventional or transmissible vaccines against emerging zoonoses in inaccessible animal populations. In both cases, cytomegaloviruses as members of the subfamily Betaherpesvirinae are particularly suitable for vaccine development as they are highly specific for their natural host species, infect a large proportion of their host population, and cause mild infections in healthy individuals.

Nov 29, 2023 | thelancet.com | Olha Puhach |Mathilde Bellon |Kenneth Adea |Meriem Bekliz

SummaryMucosal antibodies play a key role in the protection against SARS-CoV-2 infection in the upper respiratory tract, and potentially in limiting virus replication and therefore onward transmission. While systemic immunity to SARS-CoV-2 is well understood, we have a limited understanding about the antibodies present on the nasal mucosal surfaces. In this study, we evaluated SARS-CoV-2 mucosal antibodies following previous infection, vaccination, or a combination of both.

Mar 24, 2023 | paperity.org | Grégoire Michielin |Olha Puhach |Mathilde Bellon |Fatemeh Arefi

PLOS ONE, Mar 2023 This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283149&type=printable Grégoire Michielin, Fatemeh Arefi, Olha Puhach, Mathilde Bellon, Pascale Sattonnet-Roche, Arnaud G. L’Huillier, Isabella Eckerle, Benjamin Meyer, Sebastian J. Maerkl. , PLOS ONE, 2023, Volume 18, Issue 3, DOI: 10.1371/journal.pone.0283149